medigraphic.com
SPANISH

Neurología, Neurocirugía y Psiquiatría

ISSN 0028-3851 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 1

<< Back

Rev Neurol Neurocir Psiquiat 2005; 38 (1)

Prefrontal ventromedial syndrome. Report of a case

Soriano PAM, Valencia GFJ, Hernández SM, Zárate MA, Meza DE
Full text How to cite this article

Language: Spanish
References: 11
Page: 37-39
PDF size: 48.45 Kb.


Key words:

Prefrontal ventromedial syndrome, diencephalic.

ABSTRACT

It is the report of a clinical case of a patient who was diagnosed with mental and behavioural disorders secondary to injury, dysfunction or cerebral disease (prefrontal ventrodorsal syndrome) plus diencephalic syndrome, and treated in a multidisciplinary way; the man at this time is found in good conditions contrary to what due to the natural evolution of his suffering would be waited for, for over half and a year since the psychiatric treatment.


REFERENCES

  1. Eslinger P, Grattan L. Frontal lobe and frontalstriatal substrates for different forms of human cognitive flexibility. Neuropsychology 1993; (31): 17-28.

  2. Luria AR. Las funciones corticales superiores del hombre. 3a. Ed. México: Distribuciones Fontamara; 1977.

  3. Pineda D. La Función ejecutiva y sus trastornos. Neurología 2000; 30(8): 16-30.

  4. Agren H, Reibring L. PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 1994; 27: 2-6.

  5. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 1976; 33: 1193-7.

  6. Henninger GR, Charney DS, Sternberg DE. Serotonergic function in depression. Arch Gen Psychiatry 1984; 41: 398-402.

  7. Siever LJ, Murphy DL, Slater S, De la Vega E, Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotoninergic responsivity in depression. Life Sci 1984; 34: 1029-39.

  8. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Henninger GR. Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990; 47: 411-18.

  9. Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993; 614: 37–44.

  10. Yates M, Leake A, Candy JM, Fairbairn AF, McKeith IG, Ferrier IN. 5-HT2 receptor changes in major depression. Biol Psychiatry 1990; 27: 489-96.

  11. Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbitoinsular cortex. Br J Psychiatry 1997; 171: 444-8.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Neurol Neurocir Psiquiat. 2005;38